The use of cabotegravir, a bimonthly injection that prevents HIV infection, was highly effective in a new real-life study that analyzed in the longer term the use of pre-exposure prophylaxis (PrEP) injection. Exclusive material for subscribers. To have full access, access the link of the material and register.